You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lung Cancer Non Small Cell

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metabolic Response to Food in Advanced Lung Cancer

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Weight loss (%)
  • (no location specified)
Jun 30, 2023

NSCLC, NSCLC Trial in Guangzhou (Apatinib + Fluzoparib, Apatinib + Fluzoparib + Adebrelimab)

Not yet recruiting
  • NSCLC
  • Non-small Cell Lung Cancer
  • Apatinib + Fluzoparib
  • Apatinib + Fluzoparib + Adebrelimab
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Jun 27, 2023

Non Small Cell Lung Cancer Metastatic Trial (MRI)

Not yet recruiting
  • Non Small Cell Lung Cancer Metastatic
  • MRI
  • (no location specified)
May 16, 2023

Iruplinalkib in Treatment of ALK-Positive Non-Small Cell Lung

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • Jinan, Shandong, China
    Shandong Cancer Hospital and Institute
Aug 8, 2023

NSCLC Trial in Wuhan (Cadonilimab, Pemetrexed, Carboplatin)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Wuhan, Hubei, China
    Qian Chu
Aug 18, 2023

NSCLC Trial (Tislelizumab IV, Tislelizumab SC, Histology-Based Chemotherapy Doublet)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Tislelizumab IV
  • +2 more
  • (no location specified)
Oct 25, 2023

NSCLC Trial in Omaha (PLB1004)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Omaha, Nebraska
    Nebraska Cancer Specialists
Sep 19, 2023

Learn About Dacomitnib in Non-small Cell Lung Cancer Which Has

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Oct 4, 2023

Non-Small-Cell Lung Cancer Trial in Guangzhou (PLB1004)

Recruiting
  • Non-Small-Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong General Hospital
Aug 25, 2023

NSCLC, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation Trial in Fairfax (STX-721)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Fairfax, Virginia
    NEXT Virginia
Sep 18, 2023

Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

Recruiting
  • Nonsmall Cell Lung Cancer
  • +3 more
  • Genomically Guided Radiation Therapy (RT)
  • Tampa, Florida
    Moffitt Cancer Center
May 23, 2023

NSCLC Trial in Shanghai (SI-B001, SI-B003)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Jul 10, 2023

NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Crizotinib - Usual
  • Crizotinib - Study
  • Rockville, Maryland
    Medicine Invention Design, Inc. - IORG0007849
Oct 5, 2023

Cancer Medicines in Metastatic Non-small Cell Lung Cancer in

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Oslo, Norway
    Pfizer Norway
Apr 17, 2023

NSCLC Trial (SGN-B6A, docetaxel)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Aug 21, 2023

Stage IB Non-small Cell Lung Cancer

Completed
  • Stage IB Non-Small Cell Lung Carcinoma
    • Shanghai, China
      180 Fenglin Road
    Jul 29, 2023

    NSCLC Trial in Houston (Amivantamab, Tepotinib)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 9, 2023

    Advanced Non-small-cell Lung Cancer Trial in Shanghai (AK112, AK104, caboplatin)

    Not yet recruiting
    • Advanced Non-small-cell Lung Cancer
    • Shanghai, China
      Shanghai Pulmonary Hospital
    Jun 6, 2023

    Examination of Trends in Non-Small Cell Lung Cancer Patients'

    Not yet recruiting
    • Non-Small Cell Lung Cancer
      • (no location specified)
      Mar 10, 2023

      Resectable Lung Non-Small Cell Carcinoma Trial in Atlanta (procedure, radiation, other)

      Not yet recruiting
      • Resectable Lung Non-Small Cell Carcinoma
      • Biospecimen Collection
      • +2 more
      • Atlanta, Georgia
        Emory University Hospital/Winship Cancer Institute
      Aug 22, 2023

      NSCLC(NSCLC) Trial in Jinan (WX-0593 Tablets)

      Not yet recruiting
      • Non-Small Cell Lung Cancer(NSCLC)
      • WX-0593 Tablets
      • Jinan, Shandong, China
        Shandong Cancer Hospital and Institute
      Mar 1, 2023

      NSCLC, EGFR Sensitive Mutation, Adjuvant Therapy Trial in Beijing, Nanjing, Shanghai (Befotertinib + Icotinib , Icotinib +

      Recruiting
      • Non-Small Cell Lung Cancer
      • +2 more
      • Befotertinib + Icotinib placebo
      • Icotinib + Befotertinib placebo
      • Beijing, China
      • +2 more
      Sep 20, 2023

      ALK Positive NSCLC Trial in Guangzhou (Loratinib)

      Recruiting
      • ALK Positive Non-small Cell Lung Cancer
      • Guangzhou, Guangdong, China
        Guangdong Provincial Perople's Hospital
      Oct 19, 2023

      NSCLC Trial (V940, Pembrolizumab, Placebo)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • V940
      • +2 more
      • (no location specified)
      Oct 5, 2023

      Locally Advanced or Metastatic NSCLC Trial (HB1801, Taxotere)

      Not yet recruiting
      • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
      • (no location specified)
      May 8, 2023